High-Fat Diet Enhances the Liver Metastasis Potential of Colorectal Cancer through Microbiota DysbiosisOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined how a high-fat diet (HFD) influences colorectal cancer (CRC) tumorigenesis and liver metastasis through changes in gut microbiota. The researchers assessed gut barrier function and inflammation in the colorectum and liver following HFD exposure. They used 16S rRNA sequencing to characterize microbiota shifts and tested whether a specific bacterial genus could reproduce the observed barrier and inflammatory effects.
Who was studied?
The study drew on faecal samples from HFD-fed rats as well as from CRC patients with liver metastasis. Beyond this, the abstract does not provide details on sample size, age, or sex of the subjects. The rat model was used alongside human patient samples to compare microbiota changes across species.
What were the most important findings?
A high-fat diet promoted gut barrier dysfunction and inflammation in both the colorectum and liver. 16S rRNA sequencing revealed an abundance of Desulfovibrio (DSV) in both HFD-fed rats and CRC patients with hepatic metastasis. DSV itself was shown to induce colorectal barrier dysfunction and inflammation in the colorectum and liver, indicating it can independently generate a tumor-permissive microenvironment.
What are the greatest implications of this study?
These findings suggest that Desulfovibrio abundance driven by high-fat diet consumption may be a mechanistic contributor to CRC initiation and progression to liver metastasis. This positions gut microbiota composition, and DSV specifically, as a potential target for reducing metastatic risk in CRC. The results also support diet as a modifiable factor influencing the gut microenvironment relevant to cancer spread.